Navigation Links
New Understanding and Treatment for Dyslexia Revealed by The Levinson Medical Center for Learning Disabilities

Great Neck, New York (PRWEB) March 22, 2013

The recent creation of a new "bottom heavy" font by Alberto Gonzalez and Dr. Harold Levinson's prior use of enlarged, dark, thick, colored and glare-free typeset have made it easier for dyslexics to process letter and word signals. Just as important, the enhanced signal efficacy of specially designed fonts and typesets have helped further validate Dr. Levinson's signal-scrambling theory and treatment of dyslexia. It also more clearly explains why and how dyslexics rapidly and often dramatically improve when their reading and related input and output signals are medically stabilized with simple and safe inner-ear and signal-enhancing medications and nutrients.

Well over 40 million Americans suffer from dyslexia and its 100+ reading and nonreading symptoms. Despite the recognition of reversal prone dyslexics in 1896, a clear scienti?c understanding of this disorder de?ed all investigative efforts until Dr. Levinson's 4+ decades of research began in the late 1960's. Initially supported by cerebellar neurophysiologist and Nobel Laureate Sir John Eccles and outstanding others, Dr. Levinson's pioneering dyslexia concepts and inner-ear/cerebellar research have now been independently validated in world-wide studies.

For over a century, there existed the mistaken convictions that dyslexia: 1-was just a severe reading disorder, and 2- that it results when impaired processors within the thinking brain (cerebral cortex) cannot recognize the clear reading and related signals received. However, Dr. Levinson's challenging research demonstrated the exact opposite to be true. Dyslexia has many reading and non-reading symptoms and it occurs when normal reading and related brain processors fail to recognize or compensate for the distorted, reversed and scrambled signals received and transmitted. This signal-scrambling impairment was shown by Dr. Levinson due to a ?ne-tuning dysfunction within the inner-ear and its supercomputer--the cerebellum, man's lower brain and the highest brain of most animals.

One "minor" ?ne tuning problem of inner-ear origin was shown to emit multiple scrambled signals to many normal brain processors. As a result, it's possible to have 100+ diverse and even severe dyslexics symptoms and still be very bright and gifted. Clearly, the inner ear does not impair basic IQ. However, self-esteem is often decimated by constant frustration and repeated failures. Fortunately this "minor" signal impairment can be readily compensated for and now favorably treated in the vast majority of dyslexics. Thus the prognosis for dyslexics is very favorable-- especially if treatment is initiated early before secondary emotional scarring results. Most important, the medications tend to normalize the signal defect after 2-4 yrs. Thereafter, medications and special fonts are often no longer needed for improvements to continue.

Amazingly, medical treatment alone with simple and safe inner-ear and signal enhancing medications can rapidly and often dramatically improve 75-85% of dyslexics, regardless of age. 100% of dyslexics improve when holistically co-treated with effective non-medical inner-ear-related methods which include tutoring, sensory-motor integration, visual and auditory integration and processing, tinted lenses, yoga, nutrition, etc. as well as the above described fonts.

Utilizing both newly designed and traditional diagnostic methods within his medical and research center, Dr Levinson is capable of determining the dyslexic cause in almost 100% of examined patients. Even better, preschoolers can be effectively screened and pretreated-- thus preventing the typical dyslexic symptoms from appearing later on.

Readers of Dyslexia Online will be amazingly enlightened upon listening to the 100+ symptoms, 20+ "disorders" and 100+ rapid and often dramatic improvements characterizing Dr. Levinson's many dyslexic patients. Included are dyslexic quadruplets, highly gifted adults, and those who have other severe complicating disorders. They've all volunteered their content, emotions, names and photos on this newly redesigned website so as to help others as they were helped. This vital information will enable dyslexics to feel as smart as they really are and to attain dreams and ambitions that otherwise might never be theirs.

Formerly Clinical Associate Professor of Psychiatry at NYU Medical Center, Harold N. Levinson, M.D. is now Medical Director of The Levinson Medical Center for Learning Disabilities in Great Neck, New York. Considered a world-renowned psychiatrist and neurologist, he is credited with bringing about a dramatic medical breakthrough in the understanding, diagnosis and successful treatment of dyslexia and its many related signal-scrambling disturbances of the inner ear and its supercomputer, the cerebellum. The original insights and content within his many books and research papers dealing with the origins, treatment and interrelationships of dyslexia, learning disabilities, attention deficit, impulse/hyperactivity and anxiety or phobic disorders have appeared in scientific and educational journals. For additional information, visit Dyslexia Online.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Neural synchrony may be key to understanding how the human brain perceives
2. Research leads to better understanding of peripheral neuropathy
3. Mouse model improves understanding of clear cell sarcoma
4. Learn to be more understanding by watching The Bachelor (this season, anyway)
5. Understanding personality for decision-making, longevity, and mental health
6. Understanding brain tumor growth opens door for non-surgical treatment
7. New understanding of nerve damage caused by spinal cord injury could improve treatment design
8. Understanding cell organization to tackle cancer
9. Study helps bridge gap in understanding of suicide risk for African-American women
10. New understanding can lead to srategies for dealing with neurodegenerative diseases
11. After 100 years, understanding the electrical role of dendritic spines
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: